Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of La Porte: The Complete Guide for Women, Families, and Survivors
If you are a woman in City of La Porte who has undergone breast reconstruction following a mastectomy, or perhaps a cosmetic revision or “internal bra” procedure, you were likely told that the materials being placed in your body were the gold standard of modern medicine. You may have been told that Acellular Dermal Matrix (ADM) or bioabsorbable scaffolds like GalaFLEX or Phasix would provide the necessary support for your implants to look and feel natural. For many women in our City of La Porte community, however, the reality has been far different. Instead of a successful recovery, you may be facing chronic pain, severe redness, reconstruction failure, or a terrifying diagnosis like BIA-ALCL or BIA-SCC.
At Attorney911 (The Manginello Law Firm, PLLC), we recognize the courage it takes to confront a medical device manufacturer after you have already battled through a diagnosis like breast cancer or navigated a complex surgical recovery. Our Managing Partner, Ralph P. Manginello, has been licensed by the State Bar of Texas (Bar Card Number 24007597) for twenty-seven years, and our firm is deeply rooted in the Harris County legal community. We are not just a local City of La Porte resource; we are an experienced litigation team admitted to the United States District Court for the Southern District of Texas, where many of these complex product liability cases are fought.
If you suspect your surgical mesh, ADM, or scaffold has failed, you are not alone, and your symptoms are not “just part of the healing process.” We provide this definitive guide to help the women and families of City of La Porte understand the regulatory failures, the medical science, and the legal pathways toward justice. To speak with our team for a confidential, no-obligation consultation, contact us at 1-888-ATTY-911.
Understanding the Devices: ADM, Scaffolds, and Mesh in City of La Porte Breast Surgeries
To understand why so many women in City of La Porte are experiencing complications, we must first define the products used in these procedures. These devices generally fall into three categories, often used interchangeably by surgeous but possessing very different biological and regulatory profiles.
1. Acellular Dermal Matrix (ADM)
ADM is a biologic material, typically derived from human cadaver skin (allograft) or animal tissue such as porcine (pig) or bovine (cow) sources. The manufacturer “decellularizes” the tissue, leaving behind a collagen scaffold intended to allow your own cells to grow into it. In City of La Porte reconstruction cases, brands like AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), and AlloMax (BD/Bard) have been widely used to create a pocket for the breast implant.
2. Bioabsorbable Scaffolds
These are synthetic, man-made materials designed to be absorbed by your body over a period of 12 to 24 months. The most prominent example in City of La Porte is GalaFLEX, made by Galatea Surgical (now a Becton Dickinson company). These scaffolds are composed of poly-4-hydroxybutyrate (P4HB), a material meant to provide temporary support while your tissue heals.
3. Synthetic Surgical Mesh
Occasionally, permanent synthetic meshes—like those used in hernia repairs—have been used off-label in breast surgery. These are frequently made of polypropylene, a material known for causing chronic inflammation and “mesh shrinkage” when used in sensitive breast tissue.
The most critical fact for any patient in City of La Porte to understand is this: the safety and effectiveness of surgical mesh in breast surgery has not been determined by the FDA. Despite being implanted in thousands of women at prestigious medical centers serving City of La Porte, these devices entered the market through a regulatory “shortcut” that skipped the rigorous testing most patients assume is mandatory.
The 510(k) Clearance Shortcut: Why City of La Porte Patients Weren’t Warned
Most patients assume that if a device is used in a major hospital in Harris County, it must have been “FDA Approved.” In the world of medical devices, there is a massive legal difference between “FDA Approved” and “FDA Cleared.”
The vast majority of breast mesh, ADM, and scaffold products were brought to market through the 510(k) clearance pathway (21 USC §360c). Instead of proving the device was safe and effective for breast surgery through clinical trials, manufacturers only had to show the device was “substantially equivalent” to a “predicate device” already on the market.
This leads to what we call “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicate devices to get into the market. We have seen cases where a mesh used in a woman’s breast in City of La Porte traces its regulatory lineage back to a device meant for a completely different part of the anatomy. Because of this, many of these materials were never clinically tested in human breast tissue before they were marketed to City of La Porte surgeons.
Under the landmark Supreme Court ruling in Medtronic v. Lohr (518 U.S. 470), 510(k) clearance does not preempt state-law claims. This means women in City of La Porte have a clear legal path to sue manufacturers for negligence and failure to warn, as the FDA never actually “approved” the safety of these products for breast reconstruction.
Verbatim FDA Warnings: What City of La Porte Surgeons Now Know
Our firm, including associate attorney Lupe Peña, who provides fluent Spanish consultations for our City of La Porte clients, has closely monitored the shifting regulatory landscape. In recent years, the FDA has moved from quiet observation to vocal warning.
On November 9, 2023, the FDA issued a scathing letter to health care providers regarding BD Mesh Products, including GalaFLEX and Phasix. The agency stated:
“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
The FDA also identified that certain ADM products, specifically FlexHD and AlloMax, were associated with significantly higher rates of explantation, reoperation, and infection. If you were a patient at a high-volume surgical center in City of La Porte and received one of these brands, you may have been unknowingly placed at a 2.7 times higher risk for infection compared to patients whose surgeons did not use ADM.
If you are suffering from complications and your surgeon is telling you these issues are “unavoidable,” the FDA’s own data suggests otherwise. Ralph Manginello and the team at Attorney911 are currently evaluating cases for women in City of La Porte who were never warned of these elevated risks. Call us at 1-888-ATTY-911 to discuss your medical history in a private setting.
The Spectrum of Injury: From Red Breast Syndrome to BIA-ALCL
Complications from defective breast mesh and ADM in City of La Porte are not just aesthetic issues; they are often systemic medical crises. We categorize these injuries through four lenses: medical pathology, the firm’s experience with institutional liability, the contrast with generalist firms, and the specific impact on your life in City of La Porte.
Red Breast Syndrome and Endotoxin Science
Many City of La Porte patients experience a non-infectious, bright red rash over the lower portion of the breast. This is often “Red Breast Syndrome,” a condition unique to ADM. Peer-reviewed literature, including studies by Nguyen et al., suggests this is caused by endotoxins—fragments of bacteria left on the matrix during the manufacturing process. Even if the product is technically “sterile,” the endotoxin load can trigger a massive inflammatory response. Generalist personal injury firms may mistake this for a simple infection; we understand the underlying pathology required to hold the manufacturer accountable.
BIA-ALCL: The Textured Implant Cancer
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma recognized by the World Health Organization. It is frequently associated with textured surfaces, such as those found on Allergan BIOCELL implants (recalled in 2019). The pathology is specific: CD30 positive and ALK negative.
If you are a breast cancer survivor in City of La Porte who chose reconstruction to move forward with your life, only to be diagnosed with a new, device-induced lymphoma, the betrayal is profound. We are following the Allergan BIOCELL MDL 2921 in the District of New Jersey, where the first bellwether trial is currently set for October 19, 2026. This litigation is the primary vehicle for justice for BIA-ALCL victims in Harris County and across the nation.
BIA-SCC: The Emerging Threat
In September 2022, the FDA issued a safety communication regarding Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). Unlike ALCL, this cancer is found in the “capsule” or scar tissue and has been identified in both smooth and textured implants. For City of La Porte patients, this diagnosis often comes years—sometimes decades—after the original surgery.
Capsular Contracture and Reconstruction Failure
The “internal bra” technique using GalaFLEX or Phasix is often marketed as a way to prevent “bottoming out” or “lateral displacement.” However, if the scaffold fails to resorb on the projected 18-to-24-month timeline, it can cause severe capsular contracture (Baker Grade III/IV), chronic pain, and permanent deformity. In some cases, the tissue becomes so compromised that a total “flat closure” is the only remaining option, meaning the woman loses her reconstruction entirely.
Why City of La Porte Survivors Choose Attorney911
When facing a global manufacturer like AbbVie (Allergan) or Becton Dickinson, the law firm you choose matters. At Attorney911, we differentiate ourselves through our current high-profile litigation capability and our deep local ties.
We are currently lead counsel in Bermudez v. Pi Kappa Phi, a $10 million lawsuit filed in Harris County in November 2025. This case demonstrates our ability to take on massive institutional defendants like the University of Houston and national organizations. We apply this same aggressive, multi-defendant strategy to medical device litigation. We don’t just sue the manufacturer; we look at the entire chain of distribution and the hospital systems serving City of La Porte.
Lupe Peña: Bilingual Representation for Harris County
We know that City of La Porte is a diverse community. Associate Attorney Lupe Peña conducts full client consultations in fluent Spanish. In many device cases, “informed consent” was never truly achieved because the complex risks were never explained in the patient’s primary language. Lupe ensures that our Spanish-speaking clients in City of La Porte have a direct voice in their litigation without the barrier of interpreters.
Ralph Manginello’s 27 Years of Ethics and Excellence
With an Avvo Rating of 8.2 and a Martindale-Hubbell Preeminent rating, Ralph Manginello has spent nearly three decades building a reputation for integrity in Houston. He is a member of the Pro Bono College of the State Bar of Texas, a distinction that requires far exceeding the state’s goals for service to the community. When you hire us, you are hiring a firm that the Better Business Bureau (BBB) and hundreds of five-star Birdeye reviewers recognize as a leader in Texas personal injury law.
The Whistleblower: What BD Didn’t Tell Your City of La Porte Doctor
One of the most powerful elements of the current GalaFLEX and Phasix litigation is the testimony of Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was terminated in 2022 after raising internal alarms about the safety of these products.
According to his public record and whistleblower filings:
- BD allegedly withheld data regarding breast cancer recurrences in patients who received GalaFLEX during clinical trials.
- The company purportedly engaged in aggressive off-label marketing to City of La Porte surgeons before safety and effectiveness were established.
- BD allegedly failed to report hundreds of adverse events to the FDA’s MAUDE database in a timely or accurate manner.
This “investigative authority” is what separates Attorney911 from firms that only handle car accidents. We dig into the MAUDE reports and the clinical trial NCT numbers (such as NCT05190978) to find the proof that the manufacturer chose profits over the safety of women in City of La Porte.
Statutes of Limitation and the Discovery Rule in Texas
Under Texas law (Texas Civil Practice and Remedies Code § 16.003), the statute of limitations for a product liability claim is generally two years. However, because these injuries often happen inside the body and are not immediately obvious, the “Discovery Rule” is critical for City of La Porte patients.
The clock may not start ticking until the date you discovered—or reasonably should have discovered—that your injury was caused by the mesh or ADM. For many, that date was the FDA’s November 2023 letter. For others, it was an explant surgery in Harris County where the surgeon specifically identified the mesh as the source of the complication.
Because the Texas Statute of Repose (15 years from the date of first sale) also creates an absolute deadline, it is vital to contact 1-888-ATTY-911 immediately. If you wait too long, even a clear-cut case of manufacturer fraud could be legally barred.
Steps for City of La Porte Women to Take Today
If you suspect your breast reconstruction, lift, or augmentation has been compromised by a defective device, we recommend the following steps:
- Secure Your Operative Report: Contact your City of La Porte surgeon’s office or the Harris County hospital where your surgery was performed. Specifically, ask for the “Implant Log” or “Device Stickers.” This will contain the Unique Device Identifier (UDI), lot numbers, and brand names (e.g., GalaFLEX, AlloDerm, FlexHD).
- Request Your Pathology Slides: If you have already had an explant or revision surgery, your tissue samples are in a pathology lab. These slides are critical evidence. We can help you secure them so they are not destroyed after the standard retention period.
- Document Your Symptoms: Take dated photographs of any “Red Breast” symptoms, visible “rippling,” or skin erosion. Keep a journal of your pain levels and any systemic symptoms like extreme fatigue or joint pain (often associated with Breast Implant Illness).
- Consult Independent Counsel: Do not sign any “waivers” or “assistance agreements” from a device manufacturer without talking to us. Manufacturers often offer small sums for “medical out-of-pocket costs” in exchange for a full liability release that could cost you millions in future compensation.
FAQ: Defective Breast Mesh and ADM in City of La Porte
Is surgical mesh actually banned in breast surgery?
No, it is not “banned,” but as the FDA stated in 2023, it has never been “cleared or approved” for that use. Surgeons use it “off-label.” While off-label use is legal for doctors, it is illegal for manufacturers to promote products for off-label use without safety data.
I had my surgery ten years ago. Is it too late?
Not necessarily. If you were only recently diagnosed with BIA-ALCL or BIA-SCC, or if the complications were only recently linked to the mesh, the Discovery Rule may preserve your claim. Contact Ralph Manginello at 1-888-ATTY-911 for a Harris County-specific timeline analysis.
What is the average settlement for GalaFLEX or ADM cases?
Every case is different, but we look at comparable mass torts for context. The BD/Bard hernia mesh settlement in October 2024 involved nearly $1 billion to resolve 40,000 claims. For a catastrophic injury involving total reconstruction failure or cancer in City of La Porte, the damages can be significantly higher, reaching into high six- or seven-figure ranges.
Will I have to sue my doctor?
In most cases, the primary defendant is the manufacturer who misled the medical community. Under the Learned Intermediary Doctrine, manufacturers are supposed to provide surgeons with all the risks. If BD or Allergan withheld that data, the manufacturer is the liable party, not the City of La Porte surgeon who was also kept in the dark.
Contact Attorney911: Your City of La Porte Device Injury Resource
You transitioned from a survivor to a patient once again because a manufacturer decided your body could be a testing ground for 510(k) products. You deserve better than a generic law firm. You deserve a firm that understands the P4HB hydrolysis kinetics, the CD30 pathology, and the Harris County judicial landscape.
Ralph Manginello and Lupe Peña are ready to listen to your story. We work on a contingency-fee basis, meaning you pay nothing unless we recover compensation for you. We provide a safe, confidential environment for you to get the answers you deserve.
Call us today at 1-888-ATTY-911 (1-888-288-9911) or visit our Houston office at 1177 West Loop South, Suite 1600.
Hablamos español. Una consulta gratuita y confidencial está disponible con Lupe Peña. No permita que el tiempo se agote para su caso en City of La Porte.
Attorney Advertising & Legal Disclaimer:
The information on this page is for educational purposes and does not constitute legal advice. No attorney-client relationship is formed by reading this content or contacting the firm until a written representation agreement is signed. Ralph P. Manginello is the attorney responsible for this content. Past results, including the Bermudez v. Pi Kappa Phi litigation or previous multi-million dollar settlements, do not guarantee a similar outcome in your case. Every medical device injury case involves unique facts and legal challenges in the City of La Porte and Harris County jurisdictions. Case expenses may apply. The Manginello Law Firm, PLLC d/b/a Attorney911. Principal office: Houston, Texas.
